erdafitinib

Italy

Drugs containing this active substance

  • BALVERSA

    It is an anticancer drug used in adults to treat urothelial carcinoma (cancer of the bladder and urinary tract) that is either locally advanced and unresectable, or metastatic, provided that the tumor presents specific FGFR3 gene alterations and has worsened after immunotherapy.

    Form: tablets, film-coated

    Active substance Dosage
    erdafitinib -

    ATC: L01EN01

    Manufacturer: JANSSEN-CILAG INTERNATIONAL N.V.